LENSAR (NASDAQ:LNSR) Stock Gets Price Target Reduction from BTIG Research

LENSAR (NASDAQ:LNSR) had its price target trimmed by BTIG Research from $10.00 to $9.00 in a research report released on Tuesday, Marketbeat.com reports. The brokerage currently has a buy rating on the stock.

Other analysts also recently issued research reports about the stock. Loop Capital set a $11.00 price target on shares of LENSAR in a research note on Monday, September 28th. Lake Street Capital reissued a “buy” rating and issued a $13.00 price objective on shares of LENSAR in a research note on Thursday, August 13th. Wall Street Zen cut LENSAR from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. Finally, Weiss Ratings upgraded LENSAR from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, October 22nd. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, LENSAR presently has an average rating of “Hold” and an average target price of $11.00.

LENSAR Trading Up 2.6%

NASDAQ:LNSR opened at $4.70 on Tuesday. LENSAR has a twelve month low of $4.30 and a twelve month high of $12.94. The company has a market cap of $57.76 million, a price-to-earnings ratio of -11.75 and a beta of 1.03. The stock has a fifty day simple moving average of $6.50 and a 200-day simple moving average of $7.21.

LENSAR (NASDAQ:LNSR) last issued its earnings results on Tuesday, November 10th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.28). The company had revenue of $14.13 million for the quarter, compared to analysts’ expectations of $14.30 million. LENSAR had a net margin of 56.07% and a return on equity of 1,254.25%.

Institutional Investors Weigh In On LENSAR

Hedge funds have recently modified their holdings of the business. State of Wyoming bought a new stake in LENSAR during the 3rd quarter valued at $110,000. Engineers Gate Manager LP purchased a new position in LENSAR in the second quarter valued at about $63,000. Susquehanna International Group LLP bought a new position in LENSAR in the second quarter worth about $253,000. Man Group plc bought a new position in LENSAR in the second quarter worth about $445,000. Finally, Sanctuary Advisors LLC bought a new position in LENSAR in the second quarter worth about $96,000. Hedge funds and other institutional investors own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc. is a medical technology company focused on ophthalmic laser systems used in cataract surgery and other procedures involving the eye. The company develops and commercializes femtosecond laser technology designed to assist surgeons with key steps of cataract surgery, including corneal incisions, capsulotomy and lens fragmentation. Its product portfolio includes the LENSAR Laser System, which incorporates image-guidance and planning technologies intended to support precise, customized procedures.